Laquinimod prevents cuprizone-induced demyelination independent of Toll-like receptor signaling

por Kramann, Nadine, Menken, Lena, Hayardeny, Liat, Hanisch, Uwe-Karsten, Brück, Wolfgang
Publicado 2016

Immune parameters of patients treated with laquinimod, a novel oral therapy for the treatment of multiple sclerosis: results from a double-blind placebo-controlled study

por Stasiolek, Mariusz, Linker, Ralf A, Hayardeny, Liat, Bar Ilan, Oren, Gold, Ralf
Publicado 2015

Laquinimod dampens hyperactive cytokine production in Huntington's disease patient myeloid cells

por Dobson, Lucianne, Träger, Ulrike, Farmer, Ruth, Hayardeny, Liat, Loupe, Pippa, Hayden, Michael R., Tabrizi, Sarah J.
Publicado 2016

Restoration of Axon Conduction and Motor Deficits by Therapeutic Treatment with Glatiramer Acetate

por Moore, Spencer, Khalaj, Anna J, Patel, Rhusheet, Yoon, JaeHee, Ichwan, Daniel, Hayardeny, Liat, Tiwari-Woodruff, Seema K
Publicado 2014

Laquinimod reduces neuroaxonal injury through inhibiting microglial activation

por Mishra, Manoj Kumar, Wang, Janet, Keough, Michael B, Fan, Yan, Silva, Claudia, Sloka, Scott, Hayardeny, Liat, Brück, Wolfgang, Yong, V Wee
Publicado 2014

Laquinimod treatment in the R6/2 mouse model

por Ellrichmann, Gisa, Blusch, Alina, Fatoba, Oluwaseun, Brunner, Janine, Reick, Christiane, Hayardeny, Liat, Hayden, Michael, Sehr, Dominik, Winklhofer, Konstanze F., Saft, Carsten, Gold, Ralf
Publicado 2017

Author Correction: Laquinimod treatment in the R6/2 mouse model

por Ellrichmann, Gisa, Blusch, Alina, Fatoba, Oluwaseun, Brunner, Janine, Reick, Christiane, Hayardeny, Liat, Hayden, Michael, Sehr, Dominik, Winklhofer, Konstanze F., Saft, Carsten, Gold, Ralf
Publicado 2019

Therapeutic laquinimod treatment decreases inflammation, initiates axon remyelination, and improves motor deficit in a mouse model of multiple sclerosis

por Moore, Spencer, Khalaj, Anna J, Yoon, JaeHee, Patel, Rhusheet, Hannsun, Gemmy, Yoo, Timothy, Sasidhar, Manda, Martinez-Torres, Leonardo, Hayardeny, Liat, Tiwari-Woodruff, Seema K
Publicado 2013

Safety and in vivo immune assessment of escalating doses of oral laquinimod in patients with RRMS

por Ziemssen, Tjalf, Tumani, Hayrettin, Sehr, Tony, Thomas, Katja, Paul, Friedemann, Richter, Nils, Samara, Emil, Spiegelstein, Ofer, Sorani, Ella, Bar-Ilan, Oren, Mimrod, Dorit, Hayardeny, Liat
Publicado 2017

Aramchol downregulates stearoyl CoA-desaturase 1 in hepatic stellate cells to attenuate cellular fibrogenesis

por Bhattacharya, Dipankar, Basta, Brittany, Mato, Jose M., Craig, Amanda, Fernández-Ramos, David, Lopitz-Otsoa, Fernando, Tsvirkun, Darya, Hayardeny, Liat, Chandar, Vasuretha, Schwartz, Robert E., Villanueva, Augusto, Friedman, Scott L.
Publicado 2021

Laquinimod rescues striatal, cortical and white matter pathology and results in modest behavioural improvements in the YAC128 model of Huntington disease

por Garcia-Miralles, Marta, Hong, Xin, Tan, Liang Juin, Caron, Nicholas S., Huang, Yihui, To, Xuan Vinh, Lin, Rachel Yanping, Franciosi, Sonia, Papapetropoulos, Spyros, Hayardeny, Liat, Hayden, Michael R., Chuang, Kai-Hsiang, Pouladi, Mahmoud A.
Publicado 2016

Reduced astrocytic NF-κB activation by laquinimod protects from cuprizone-induced demyelination

por Brück, Wolfgang, Pförtner, Ramona, Pham, Trinh, Zhang, Jingya, Hayardeny, Liat, Piryatinsky, Victor, Hanisch, Uwe-Karsten, Regen, Tommy, van Rossum, Denise, Brakelmann, Lars, Hagemeier, Karin, Kuhlmann, Tanja, Stadelmann, Christine, John, Gareth R., Kramann, Nadine, Wegner, Christiane
Publicado 2012

Gene expression studies of a human monocyte cell line identify dissimilarities between differently manufactured glatiramoids

por Kolitz, Sarah, Hasson, Tal, Towfic, Fadi, Funt, Jason M., Bakshi, Shlomo, Fowler, Kevin D., Laifenfeld, Daphna, Grinspan, Augusto, Artyomov, Maxim N., Birnberg, Tal, Schwartz, Rivka, Komlosh, Arthur, Hayardeny, Liat, Ladkani, David, Hayden, Michael R., Zeskind, Benjamin, Grossman, Iris
Publicado 2015

Arachidyl amido cholanoic acid improves liver glucose and lipid homeostasis in nonalcoholic steatohepatitis via AMPK and mTOR regulation

por Fernández-Ramos, David, Lopitz-Otsoa, Fernando, Delacruz-Villar, Laura, Bilbao, Jon, Pagano, Martina, Mosca, Laura, Bizkarguenaga, Maider, Serrano-Macia, Marina, Azkargorta, Mikel, Iruarrizaga-Lejarreta, Marta, Sot, Jesús, Tsvirkun, Darya, van Liempd, Sebastiaan Martijn, Goni, Felix M, Alonso, Cristina, Martínez-Chantar, María Luz, Elortza, Felix, Hayardeny, Liat, Lu, Shelly C, Mato, José M
Publicado 2020

Role of aramchol in steatohepatitis and fibrosis in mice

por Iruarrizaga‐Lejarreta, Marta, Varela‐Rey, Marta, Fernández‐Ramos, David, Martínez‐Arranz, Ibon, Delgado, Teresa C, Simon, Jorge, Gutiérrez‐de Juan, Virginia, delaCruz‐Villar, Laura, Azkargorta, Mikel, Lavin, José L., Mayo, Rebeca, Van Liempd, Sebastiaan M., Aurrekoetxea, Igor, Buqué, Xabier, Delle Cave, Donatella, Peña, Arantza, Rodríguez‐Cuesta, Juan, Aransay, Ana M., Elortza, Felix, Falcón‐Pérez, Juan M., Aspichueta, Patricia, Hayardeny, Liat, Noureddin, Mazen, Sanyal, Arun J., Alonso, Cristina, Anguita, Juan, Martínez‐Chantar, María Luz, Lu, Shelly C., Mato, José M.
Publicado 2017

Metabolic subtypes of patients with NAFLD exhibit distinctive cardiovascular risk profiles

por Martínez‐Arranz, Ibon, Bruzzone, Chiara, Noureddin, Mazen, Gil‐Redondo, Ruben, Mincholé, Itziar, Bizkarguenaga, Maider, Arretxe, Enara, Iruarrizaga‐Lejarreta, Marta, Fernández‐Ramos, David, Lopitz‐Otsoa, Fernando, Mayo, Rebeca, Embade, Nieves, Newberry, Elizabeth, Mittendorf, Bettina, Izquierdo‐Sánchez, Laura, Smid, Vaclav, Arnold, Jorge, Iruzubieta, Paula, Pérez Castaño, Ylenia, Krawczyk, Marcin, Marigorta, Urko M., Morrison, Martine C., Kleemann, Robert, Martín‐Duce, Antonio, Hayardeny, Liat, Vitek, Libor, Bruha, Radan, Aller de la Fuente, Rocío, Crespo, Javier, Romero‐Gomez, Manuel, Banales, Jesus M, Arrese, Marco, Cusi, Kenneth, Bugianesi, Elisabetta, Klein, Samuel, Lu, Shelly C., Anstee, Quentin M., Millet, Oscar, Davidson, Nicholas O., Alonso, Cristina, Mato, José M.
Publicado 2022